Context Therapeutics Inc.
CNTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $61 | $18 | $10 | $8 |
| - Cash | $94 | $14 | $35 | $50 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$33 | $4 | -$25 | -$42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$30 | -$25 | -$15 | -$10 |
| % Margin | – | – | – | – |
| Net Income | -$27 | -$24 | -$15 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.46 | -1.5 | -0.93 | -3.69 |
| % Growth | 69.3% | -61.3% | 74.8% | – |
| Operating Cash Flow | -$15 | -$21 | -$14 | -$9 |
| Capital Expenditures | -$15 | $0 | -$1 | -$0 |
| Free Cash Flow | -$29 | -$21 | -$14 | -$9 |